TXN and hepatocellular carcinoma: Correspondingly, Sumida et al. [36] suggested that thioredoxin may therefore be responsible for the pathological mechanism of HCV-related hepatic fibrogenesis, and Tamai et al. [44] reported that serum thioredoxin levels were potential clinical biomarkers that predict patient prognosis in HCV-related HCC.